We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Dorsolateral Prefrontal Cortex Glutamate/Gamma-Aminobutyric Acid (GABA) Alterations in Clinical High Risk and First-Episode Schizophrenia: A Preliminary 7-T Magnetic Resonance Spectroscopy Imaging Study.
- Authors
Mayeli, Ahmad; Sonnenschein, Susan F.; Yushmanov, Victor E.; Wilson, James D.; Blazer, Annie; Foran, William; Perica, Maria; Calabro, Finnegan J.; Luna, Beatriz; Hetherington, Hoby P.; Sarpal, Deepak K.; Ferrarelli, Fabio
- Abstract
Converging lines of evidence suggest that an imbalance between excitation and inhibition is present in the dorsolateral prefrontal cortex (DLPFC) of schizophrenia (SCZ). Gamma-aminobutyric-acid (GABA) and, to a lesser extent, glutamate (Glu) abnormalities were reported in the DLPFC of SCZ patients, especially on the right hemisphere, by post-mortem studies. However, in vivo evidence of GABA, Glu, and Glu/GABA DLPFC abnormalities, particularly on the right side and the early stages of illness, is limited. In this preliminary study, we utilized 7-Tesla magnetic resonance spectroscopic imaging (MRSI) to investigate bilateral Glu/Creatine (Cre), GABA/Cre, and Glu/GABA in the DLPFC of sixteen first episode schizophrenia (FES), seventeen clinical high risk (CHR), and twenty-six healthy comparison (HC) subjects. FES and CHR had abnormal GABA/Cre and Glu/GABA in the right DLPFC (rDLPFC) compared with HC participants, while no differences were observed in the left DLPFC (lDLPFC) among the three groups. Furthermore, HC had higher Glu/GABA in rDLPFC compared to lDLPFC (R > L), whereas the opposite relationship (R < L) was observed in the DLPFC Glu/GABA of FES patients. Altogether, these findings indicate that GABA/Cre and Glu/GABA DLPFC alterations are present before illness manifestation and worsen in FES patients, thus representing a putative early pathophysiological biomarker for SCZ and related psychotic disorders.
- Subjects
NUCLEAR magnetic resonance spectroscopy; MAGNETIC resonance imaging; PREFRONTAL cortex; DIAGNOSTIC imaging; SCHIZOPHRENIA; IRON sulfides
- Publication
International Journal of Molecular Sciences, 2022, Vol 23, Issue 24, p15846
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms232415846